← Browse by Condition
Medical Condition

thalassemia beta

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT05736419 Phase 2
Recruiting

A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)

Enrollment
24 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
View Trial →